Received: 14 October 2020
Accepted: 11 January 2021
First Online: 9 March 2021
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (University of British Columbia – Providence Health Research Ethics Board H20–00335 and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: AT: Consultant: Olympus, Starfish Medical; Sanofi Advisory Board.AJ: Advisory Board: Sanofi Genzyme, GSK; Consultant: SaNOtize Research and Development Corp., Ondine Biomedical, CoMotion Inc., iView Therapeutics; Speaker: Vertex Pharmaceuticals.LS: Clinical trial support: GSK, Roche, AstraZeneca, Optinose; Honorarium/Advisory board: Sanofi, Mylan; Speaker fees: Medtronic, Mylan, Sanofi.SK: Research Funding: CIHR (Canadian Institute of Health Research), Physician Services Incorporated (PSI), The Ottawa Hospital Academic Medical Organisation (TOHAMO).Medtronic, Sanofi, AstraZeneca, Novartis, Roche / Genentech, GSK; Speaker: Mylan, Sanofi, ALK; Consultant: Sanofi.DS: Industry sponsored research: GSK; Advisory board: Sanofi; Speaking fees: Medtronic.BR: Consultant: Stryker, Trudell Medical and Smith & Nephew.MT: Industry sponsored research: Sanofi and AstraZeneca; Consultant: Sanofi, AstraZeneca, and Novartis.IW: Shareholder: Proteocyte Diagnostics Inc.; Consultant: Sanofi Genzyme, GSK.JS, KS, JL: Advisory Board: Sanofi.CC, EW, AJ, EM, YC, MD: None.